A significant number of self-reactive T cell clones escape thymic negative selection and are released into the periphery, where some are potentially pathogenic. The clonal expansion of self-reactive T cells is known to be limited during initial antigen encounter by apoptotic or anergic mechanisms, regulatory CD4 ؉ T cells, and cytokines. Here we report that superimposed on these mechanisms, during the evolution of autoimmunity in experimental autoimmune encephalomyelitis (EAE), CD8 ؉ T cells are induced, which fine-tune the peripheral self-reactive T cell receptor (TCR) repertoire. We assayed the myelin basic protein-reactive TCR repertoire in naive, EAE-recovered mice as well as EAE-recovered mice depleted of CD8 ؉ T cells by TCRV surface expression, complementarity-determining region 3 length distribution, and complementarity-determining region 3 sequencing analysis. In EAE-recovered mice, certain myelin basic protein-reactive CD4 ؉ V8.2 ؉ clones are significantly decreased and this decrease is not observed if CD8 ؉ T cells were depleted from these mice. The clones that persist in CD8 ؉ T cell-intact mice are highly diverse in contrast to the clones expanded in CD8 ؉ T cell-depleted mice, which are dominated by the significant outgrowth of a few clones. Importantly, the T cell clones that expand in the absence of CD8 ؉ T cell control are enriched in potentially pathogenic self-reactive T cell clones capable of inducing EAE in vivo.T hymocytes expressing T cell receptors (TCRs) with high affinity for self-peptide͞MHC complexes undergo apoptosis and are deleted centrally in the thymus. However, recent experiments have highlighted the fact that many self-reactive T cells with low to intermediate affinity for self-antigen escape thymic negative selection and are released into the periphery. Although these selfreactive T cells display relatively low avidity to self-peptide͞MHC complexes, they are capable of self-peptide-driven proliferation and some may differentiate into potentially pathogenic effector cells (1-4). Thus, mechanisms that normally regulate the outgrowth or function of these self-reactive T cells may ultimately control the initiation and progression of autoimmune disease. One level of control resides at the initial clonal activation of the TCR itself by MHC͞peptide complexes and, reminiscent of thymic negative selection, involves antigen-induced apoptosis. For example, a series of experiments by Anderton et al. (5) demonstrated that immunization of B10PL mice with the encephalitogenic NH 2 -terminalacetylated nanopeptide from mouse myelin basic protein (MBP), 1-9Nac MBP, induces experimental autoimmune encephalomyelitis (EAE) and triggers the proliferation of a heterogeneous population of T cells that express diverse TCRs with varying affinities for this encephalitogenic peptide (5). Interestingly, mutated forms of 1-9Nac MBP, which bind to MBP-reactive T cells with very high affinity, trigger the T cells to undergo apoptosis and these peptides are incapable of inducing EAE. In contrast, the nonmu...